| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 3,153,527 | 2,968,380 | 2,374,240 | | Cost of Revenue | 2,164,675 | 2,047,989 | 1,639,187 | | | Gross Profit | 988,852 | 920,391 | 735,053 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 597,098 | 582,643 | 496,637 | | Non Recurring | 113,214 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 278,540 | 337,748 | 238,416 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11,952) | 998 | 3,448 | | Earnings Before Interest And Taxes | 266,588 | 338,746 | 241,864 | | Interest Expense | 14,944 | 11,029 | 8,344 | | Income Before Tax | 251,644 | 327,717 | 233,520 | | Income Tax Expense | 109,081 | 130,552 | 92,495 | | Minority Interest | (6,515) | (15,860) | (4,871) | | | | Net Income From Continuing Ops | 110,699 | 183,102 | 137,323 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 110,699 | 183,102 | 137,323 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $110,699 | $183,102 | $137,323 |
|
0.31% Nasdaq 
Income Statement
